Yubo International Biotech Ltd

yubogroup.com

What Do They Do?

Sells respiratory products directly to consumers and offers other healthcare and personal-care products, along with cell testing and health-management consulting services.

How Do They Make Money?

Customers buy health-management services under agreements and health and personal-care products; product sales take place when products are delivered to customers.

FY2025 revenue

Who Are Their Customers?

Buyers include customers of health and personal-care products and users of cell-testing and health-management consulting services; nebulizers are sold directly to consumers through the online e-commerce platform.

Customers above 10% of revenue, FY2025

of revenue from one customer

Do Revenues Turn Into Profits?

No. It lost $1.1M in FY2025.

Operating income, FY2025

−9615% of revenue

▼ −33% (Loss) vs FY2024 (−$1.8M, −51006%)

Net income, FY2025

−8737% of revenue

▼ −39% (Loss) vs FY2024 (−$1.8M, −51171%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: vs $0 in Q2 FY2025
Net income: ▲ +8% (Loss); vs −$230.3K in Q2 FY2025

Shrinking. Revenue fell 99% in 4 years, from $1.2M in FY2021 to $12.4K in FY2025, about 68% a year.

Who Do They Compete With?

Competes with VCANBIO CELL&GENE

Comments